DCF — MEDICAL CITY ARLINGTON
Enterprise Value: $283.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$283.6M
Enterprise Value
$72.2M
PV of Cash Flows
$211.4M
PV of Terminal Value
$340.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $458.3M | $39.0M | 9.0% | $12.7M | $11.5M |
| Year 2 | $472.0M | $44.8M | 10.0% | $16.6M | $13.7M |
| Year 3 | $486.2M | $51.1M | 11.0% | $20.7M | $15.6M |
| Year 4 | $500.8M | $55.1M | 11.0% | $23.2M | $15.9M |
| Year 5 | $515.8M | $58.0M | 11.0% | $24.9M | $15.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $283.6M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$444.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000089899036
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5